Yahoo
    LSE - Delayed Quote GBp

    AstraZeneca PLC (AZN.L)

    Get top stock picks
    12,006.00 -140.00 (-1.15%)
    At close: September 4 at 5:15:00 PM GMT+1
    Get top stock picks
    Loading Chart for AZN.L
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Haleon And 2 British AI Healthcare Stocks To Watch

    Haleon And 2 British AI Healthcare Stocks To Watch
    Simply Wall St. 1d ago
    ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

    ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
    Business Wire 1d ago
    AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah

    AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah
    PREMIUM
    MT Newswires 1d ago
    Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer

    Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer
    Business Wire 1d ago
    This week in charts: China deals, stock flatlines and Lilly’s M&A spree

    This week in charts: China deals, stock flatlines and Lilly’s M&A spree
    BioPharma Dive 2d ago
    C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreement

    C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreement
    GlobeNewswire 2d ago
    Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?

    Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?
    Zacks 2d ago
    Osteosarcoma Market is Set to Rise by 2036 as 8 Emerging Therapies Set to Drive Future Growth | DelveInsight

    Osteosarcoma Market is Set to Rise by 2036 as 8 Emerging Therapies Set to Drive Future Growth | DelveInsight
    PR Newswire 2d ago
    The Zacks Analyst Blog Highlights AMD, Costco, AstraZeneca, Peoples Bancorp of North Carolina and Spruce Power

    The Zacks Analyst Blog Highlights AMD, Costco, AstraZeneca, Peoples Bancorp of North Carolina and Spruce Power
    Zacks 3d ago
    CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor

    CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
    Zacks Small Cap Research 3d ago
    TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)

    TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)
    Simply Wall St. 3d ago

    Related Tickers

    GSK.L
    NOVN.SW
    SAN.PA
    ROG.SW
    GSK
    SNY
    BAYN.DE
    NOVO-B.CO
    PFEB.F
    NOV.DE
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: